Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease

被引:27
|
作者
Zekonyte, Jurgita [1 ]
Sakai, Kenji [2 ]
Nicoll, James A. R. [3 ]
Weller, Roy O. [3 ]
Carare, Roxana O. [3 ]
机构
[1] Univ Southampton, Fac Engn & Environm, Southampton SO9 5NH, Hants, England
[2] Kanazawa Univ Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan
[3] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2016年 / 1862卷 / 05期
基金
英国工程与自然科学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
Apolipoprotein E; Perivascular clearance pathways; Laminin; Atomic force microscopy; Amyloid-beta; Cerebral amyloid angiopathy; Alzheimer's disease; ISOFORM-SPECIFIC BINDING; APOLIPOPROTEIN-E; FORCE SPECTROSCOPY; ANGIOPATHY; PROTEIN; BRAIN; ATTACHMENT; CLEARANCE; DRAINAGE; REMOVAL;
D O I
10.1016/j.bbadis.2015.08.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of amyloid-beta (A beta) in plaques in the brain and in artery walls as cerebral amyloid angiopathy indicates a failure of elimination of A beta from the brain with age and Alzheimer's disease. A major pathway for elimination of A beta and other soluble metabolites from the brain is along basement membranes within the walls of cerebral arteries that represent the lymphatic drainage pathways for the brain. The motive force for the elimination of A beta along this perivascular pathway appears to be the contrary (reflection) wave that follows the arterial pulse wave. Following injection into brain parenchyma, A beta rapidly drains out of the brain along basement membranes in the walls of cerebral arteries; such drainage is impaired in apolipoprotein E epsilon 4 (ApoE4) mice. For drainage of A beta to occur in a direction contrary to the pulse wave, some form of attachment to basement membrane would be required to prevent reflux of A beta back into the brain during the passage of the subsequent pulse wave. In this study, we show first that apolipoprotein E co-localizes with A beta in basement membrane drainage pathways in the walls of arteries. Secondly, we show by Atomic Force Microscopy that attachment of ApoE4/A beta complexes to basement membrane laminin is significantly weaker than ApoE3/A beta complexes. These results suggest that perivascular elimination of ApoE4/A beta complexes would be less efficient than with other isoforms of apolipoprotein E, thus endowing a higher risk for Alzheimer's disease. Therapeutic correction for ApoE4/A beta/laminin interactions may increase the efficiency of elimination of A beta in the prevention of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock. (c) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 50 条
  • [1] The molecular spectrum of amyloid-beta (Aβ) in neurodegenerative diseases beyond Alzheimer's disease
    Ichimata, Shojiro
    Yoshida, Koji
    Li, Jun
    Rogaeva, Ekaterina
    Lang, Anthony E.
    Kovacs, Gabor G.
    BRAIN PATHOLOGY, 2023,
  • [3] Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease
    Li, You-Yue
    Guo, Dan -Dan
    Duan, Ruo-Nan
    Li, Yi
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (04):
  • [4] Editorial on,"Amyloid-beta clearance in Alzheimer's disease"
    Marr, Robert A.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [5] The Interplay Between Accumulation of Amyloid-Beta and Tau Proteins, PANoptosis, and Inflammation in Alzheimer’s Disease
    Xianbo Zhuang
    Jie Lin
    Yamin Song
    Ru Ban
    Xin Zhao
    Zhangyong Xia
    Zheng Wang
    Guifeng Zhang
    NeuroMolecular Medicine, 27 (1)
  • [6] Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease
    Xiang, Yang
    Bu, Xian-Le
    Liu, Yu-Hui
    Zhu, Chi
    Shen, Lin-Lin
    Jiao, Shu-Sheng
    Zhu, Xiao-Yan
    Giunta, Brian
    Tan, Jun
    Song, Wei-Hong
    Zhou, Hua-Dong
    Zhou, Xin-Fu
    Wang, Yan-Jiang
    ACTA NEUROPATHOLOGICA, 2015, 130 (04) : 487 - 499
  • [7] Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease
    Moro, Maria Luisa
    Phillips, Andrew Stephen
    Gaimster, Katie
    Paul, Christian
    Mudher, Amritpal
    Nicoll, James A. R.
    Boche, Delphine
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 3
  • [8] Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer's disease
    Raulin, Ana-Caroline
    Doss, Sydney V.
    Heckman, Michael G.
    Craver, Emily C.
    Li, Zonghua
    Ikezu, Tadafumi C.
    Sekiya, Hiroaki
    Liu, Chia-Chen
    Martens, Yuka A.
    Rosenberg, Cassandra L.
    Kuchenbecker, Lindsey A.
    Deture, Michael
    Reichard, R. Ross
    Nguyen, Aivi T.
    Constantopoulos, Eleni
    Larsen, Rachel A.
    Kounaves, Emmaline K.
    Murray, Melissa E.
    Dickson, Dennis W.
    Petersen, Ronald C.
    Bu, Guojun
    Kanekiyo, Takahisa
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01)
  • [9] TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease
    La Rosa, Francesca
    Agostini, Simone
    Piancone, Federica
    Marventano, Ivana
    Hernis, Ambra
    Fenoglio, Chiara
    Galimberti, Daniela
    Scarpini, Elio
    Saresella, Marina
    Clerici, Mario
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [10] The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer's disease
    Zhang, Yan-Li
    Wang, Juan
    Zhang, Zhi-Na
    Su, Qiang
    Guo, Jun-Hong
    NEURAL REGENERATION RESEARCH, 2022, 17 (11) : 2355 - 2363